JRT-39

N/A

Report date: 2024/10/18 17:01:20
NME

Base Information

Drug NameJRT-39
Drug Alias NameJRT39
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApoptosis inhibitor 5 replacementApoptotic chromatin condensation inducer in the nucleus inhibitors
TargetsApoptosis inhibitor 5Apoptotic chromatin condensation inducer in the nucleus
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A